Startup uses coated RNA particles, administered as a feed supplement, to trigger a cell reaction that disables viral infections in shrimp and other water species
/PRNewswire/ ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health.
[x]
How we handle your data
We never share, sell or distribute our subscribers’ data.
You may at any time unsubsribe from our newsletters, and request that we erase all information stored about you.
Please check our Privacy policy for more details.
[x]
We use MailChimp as our email campaign platform.
By subscribing, you agree that the information you provide will be transferred to MailChimp for processing in accordance with their
privacy policy and terms.
Subscribe
Thank you. Please check your inbox to confirm your selection and start receiving newsletters.
Next
Share
Overcoming serious doubts, Alaska’s salmon processors managed to squeak out a season this summer – but it came at a cost.
According to a McDowell Group report, processors spent as much as USD 50 million (EUR 42.4 million) on COVID-19 protocol compliance, which included moving workers into Alaska early for quarantine, putting them up in hotels for their quarantine period, flying them on chartered planes, food costs, and paying for significant coronavirus testing and personal protective equipment, as well as security to ensure closed campuses. In a few cases, companies had medical professionals embedded onsite in remote locations to ensure care to their employees (and to limit any potential spread of coronavirus that would have crippled the functionality of the facility).